clg561
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2013 (NCT01835015)
Timeline
Indications
Mechanism of action
- Complement factor BINHIBITOR
CFB inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- clg561
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02515942 | Phase 2 | Sep 25, 2015 | Alcon, Novartis |
| NCT01835015 | Phase 1 | May 1, 2013 | Alcon |
Showing 2 of 2 trials
Page 1 / 1